EMERALD HUGGINS: Open Payments
NPI 1932803798 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 18 payments from 7 companies in 2025. Trend: 2023 $616 · 2024 $1,746 · 2025 $883
Food & beverage: $781Education: $101
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $188 |
| E.R. Squibb & Sons, L.L.C. | 4 | $182 |
| Teva Pharmaceuticals USA, Inc. | 5 | $169 |
| Alkermes, Inc. | 2 | $153 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, LYBALVI, ABILIFY ASIMTUFII, UZEDY, INGREZZA, ARISTADA.
Industry payments across AZ — which companies pay providers there.
